A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Some uncertainties as we head into the new week. Blustery, wet start with the main wind event on Tuesday night. Hill snow possible Thursday
Eagle-eyed Twitter users spotted that a campaign photo the party claimed was in Stoke on Trent, was actually in Bolton.
Grey and gloomy on Sunday. Winds increase overnight...